Literature DB >> 31960892

Differential network analysis of multiple human tissue interactomes highlights tissue-selective processes and genetic disorder genes.

Omer Basha1, Chanan M Argov1, Raviv Artzy1, Yazeed Zoabi1, Idan Hekselman1, Liad Alfandari1, Vered Chalifa-Caspi2, Esti Yeger-Lotem1,2.   

Abstract

MOTIVATION: Differential network analysis, designed to highlight network changes between conditions, is an important paradigm in network biology. However, differential network analysis methods have been typically designed to compare between two conditions and were rarely applied to multiple protein interaction networks (interactomes). Importantly, large-scale benchmarks for their evaluation have been lacking.
RESULTS: Here, we present a framework for assessing the ability of differential network analysis of multiple human tissue interactomes to highlight tissue-selective processes and disorders. For this, we created a benchmark of 6499 curated tissue-specific Gene Ontology biological processes. We applied five methods, including four differential network analysis methods, to construct weighted interactomes for 34 tissues. Rigorous assessment of this benchmark revealed that differential analysis methods perform well in revealing tissue-selective processes (AUCs of 0.82-0.9). Next, we applied differential network analysis to illuminate the genes underlying tissue-selective hereditary disorders. For this, we curated a dataset of 1305 tissue-specific hereditary disorders and their manifesting tissues. Focusing on subnetworks containing the top 1% differential interactions in disease-relevant tissue interactomes revealed significant enrichment for disorder-causing genes in 18.6% of the cases, with a significantly high success rate for blood, nerve, muscle and heart diseases.
SUMMARY: Altogether, we offer a framework that includes expansive manually curated datasets of tissue-selective processes and disorders to be used as benchmarks or to illuminate tissue-selective processes and genes. Our results demonstrate that differential analysis of multiple human tissue interactomes is a powerful tool for highlighting processes and genes with tissue-selective functionality and clinical impact.
AVAILABILITY AND IMPLEMENTATION: Datasets are available as part of the Supplementary data. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31960892     DOI: 10.1093/bioinformatics/btaa034

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  5 in total

Review 1.  Differential Co-Expression Analyses Allow the Identification of Critical Signalling Pathways Altered during Tumour Transformation and Progression.

Authors:  Aurora Savino; Paolo Provero; Valeria Poli
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

2.  The landscape of molecular chaperones across human tissues reveals a layered architecture of core and variable chaperones.

Authors:  Netta Shemesh; Juman Jubran; Shiran Dror; Eyal Simonovsky; Omer Basha; Chanan Argov; Idan Hekselman; Mehtap Abu-Qarn; Ekaterina Vinogradov; Omry Mauer; Tatiana Tiago; Serena Carra; Anat Ben-Zvi; Esti Yeger-Lotem
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 14.919

3.  Network analysis reveals rare disease signatures across multiple levels of biological organization.

Authors:  Pisanu Buphamalai; Tomislav Kokotovic; Vanja Nagy; Jörg Menche
Journal:  Nat Commun       Date:  2021-11-09       Impact factor: 14.919

4.  HLH-1 Modulates Muscle Proteostasis During Caenorhabditis elegans Larval Development.

Authors:  Khairun Nisaa; Anat Ben-Zvi
Journal:  Front Cell Dev Biol       Date:  2022-06-06

5.  Predicting mechanical ventilation effects on six human tissue transcriptomes.

Authors:  Judith Somekh; Nir Lotan; Ehud Sussman; Gur Arye Yehuda
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.